Objective: Literature is quite poor about the clinical effects of novel psychoactive substances (NPS) and the long-term consequences of NPS use in psychiatric patients. Consequently, it is of the greatest interest to examine which effects NPS can exert in patients with previous severe mental illness (SMI), such as psychotic patients. The aim of this work was a comprehensive review about NPS use in patients with SMI. Methods: We searched Medline or PubMed for relevant English-language citations and reviews describing relationships between NPS use and mental disorders, as well as for the main groups of substances and associated psychiatric manifestations. All studies reporting single case or case series of patients were selected. Results: The NPS use in patients with SMI is probably underestimated. The one existing systematic review considers only 14 studies, 12 of which are case reports. Most clinical results report acute symptom exacerbation of preexisting psychosis. Paranoid, mood, and aggression symptoms occur more frequently. Conclusions: NPS use could modify clinical features of SMI, but these conclusions cannot be generalizable. More evidence is needed to establish the causal and effective connection between NPS use and course of illness, type of psychiatric symptoms, and outcome of treatment in terms of adherence or response.

Novel psychoactive substances (NPS) use in severe mental illness (SMI) patients. Potential changes in the phenomenology of psychiatric diseases / Bersani, Giuseppe; Prevete, Elisabeth. - In: HUMAN PSYCHOPHARMACOLOGY. - ISSN 0885-6222. - 32:3(2017). [10.1002/hup.2591]

Novel psychoactive substances (NPS) use in severe mental illness (SMI) patients. Potential changes in the phenomenology of psychiatric diseases

Bersani Giuseppe
;
Prevete Elisabeth
2017

Abstract

Objective: Literature is quite poor about the clinical effects of novel psychoactive substances (NPS) and the long-term consequences of NPS use in psychiatric patients. Consequently, it is of the greatest interest to examine which effects NPS can exert in patients with previous severe mental illness (SMI), such as psychotic patients. The aim of this work was a comprehensive review about NPS use in patients with SMI. Methods: We searched Medline or PubMed for relevant English-language citations and reviews describing relationships between NPS use and mental disorders, as well as for the main groups of substances and associated psychiatric manifestations. All studies reporting single case or case series of patients were selected. Results: The NPS use in patients with SMI is probably underestimated. The one existing systematic review considers only 14 studies, 12 of which are case reports. Most clinical results report acute symptom exacerbation of preexisting psychosis. Paranoid, mood, and aggression symptoms occur more frequently. Conclusions: NPS use could modify clinical features of SMI, but these conclusions cannot be generalizable. More evidence is needed to establish the causal and effective connection between NPS use and course of illness, type of psychiatric symptoms, and outcome of treatment in terms of adherence or response.
2017
novel psychoactive substances; severe mental illness; mentally ill persons
01 Pubblicazione su rivista::01a Articolo in rivista
Novel psychoactive substances (NPS) use in severe mental illness (SMI) patients. Potential changes in the phenomenology of psychiatric diseases / Bersani, Giuseppe; Prevete, Elisabeth. - In: HUMAN PSYCHOPHARMACOLOGY. - ISSN 0885-6222. - 32:3(2017). [10.1002/hup.2591]
File allegati a questo prodotto
File Dimensione Formato  
Bersani_Novel-psychoactive-substances_2017.pdf

accesso aperto

Tipologia: Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza: Tutti i diritti riservati (All rights reserved)
Dimensione 148.24 kB
Formato Adobe PDF
148.24 kB Adobe PDF

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/1272838
Citazioni
  • ???jsp.display-item.citation.pmc??? 2
  • Scopus 12
  • ???jsp.display-item.citation.isi??? 11
social impact